방사선생물학

본문글자크기
  • [Cell Death Dis.] PLOD3 promotes lung metastasis via regulation of STAT3.

    KIRAMS / 백정화, 김은호*, 황상구*

  • 출처
    Cell Death Dis.
  • 등재일
    2018 Nov 15
  • 저널이슈번호
    9(12):1138. doi: 10.1038/s41419-018-1186-5.
  • 내용

    바로가기  >

    Abstract
    Procollagen-lysine, 2-oxoglutarate 5-dioxygenase (PLOD3), a membrane-bound homodimeric enzyme, hydroxylates lysyl residues in collagen-like peptides; however, its role in lung cancer is unknown. This study aimed to investigate the role of PLOD3 as a pro-metastatic factor and to elucidate the underlying mechanism. First, we experimentally confirmed the release of PLOD3 in circulation in animal models, rendering it a potential serum biomarker for lung cancer in humans. Thereafter, we investigated the effects of PLOD3 overexpression and downregulation on cancer cell invasion and migration in vitro and in vivo, using human lung cancer cell lines and a mouse tumor xenograft model, respectively. Further, PLOD3 levels were determined in lung tissue samples from lung cancer patients. Functional analyses revealed that PLOD3 interacts with STAT3, thereby expressing matrix metalloproteinases (MMP-2 and MMP-9) and with urokinase plasminogen activator (uPA) to enhance tumor metastasis. PLOD3 and the STAT3 pathway were significantly correlated in the metastatic foci of lung cancer patients; PLOD3-STAT3 levels were highly correlated with a poor prognosis. These results indicate that PLOD3 promotes lung cancer metastasis in a RAS-MAP kinase pathway-independent manner. Therefore, secreted PLOD3 serves as a potent inducer of lung cancer metastasis and a potential therapeutic target to enhance survival in lung cancer.

     


    Author information

    Baek JH1,2, Yun HS1, Kwon GT1, Kim JY1, Lee CW2, Song JY1, Um HD1, Kang CM1, Park JK1, Kim JS1, Kim EH3, Hwang SG4.
    1
    Division of Radiation Biomedical Research, Korea Institute of Radiological and Medical Sciences, Seoul, 01812, Korea.
    2
    Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon, 440-746, Korea.
    3
    Division of Radiation Biomedical Research, Korea Institute of Radiological and Medical Sciences, Seoul, 01812, Korea. eh140149@kirams.re.kr.
    4
    Division of Radiation Biomedical Research, Korea Institute of Radiological and Medical Sciences, Seoul, 01812, Korea. sgh63@kcch.re.kr.

  • 편집위원

    Procollagen-lysine, 2-oxoglutarate 5-dioxygenase (PLOD3)는 폐암에서의 기능이 잘 알려지지 않은 membrane-bound homodimeric enzyme으로 collagen-like peptides의 lysyl residue를 hydroxylation하는데 관여한다. 본 연구에서는 분비된 PLOD3가 RAS-MAP kinase pathway를 통해 폐암의 전이를 촉진함을 규명함으로써 폐암 치료의 potential therapeutic target이 될 수 있음을 밝혔다.

    2018-12-14 16:56:10

  • 덧글달기
    덧글달기
       IP : 18.118.32.213

    등록